2017 News

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
05/24/17IRIDEX To Present At The Jefferies 2017 Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 24, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New York, NY. IRIDEX's management is scheduled to present on Wednesday, June 7, 2017 at 4:30pm ET.  Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.  About IRIDEX IRIDEX Corporation was founded in 1989 and is a w... 
Printer Friendly Version
05/04/17IRIDEX Announces Presentation Of Data Demonstrating Safety And Efficacy Of Micropulse® Technology At Upcoming Industry Conferences
Results will be highlighted at upcoming ASCRS congress May 5-9 and ARVO annual meeting May 7-11 MOUNTAIN VIEW, Calif., May 4, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the presentation of data demonstrating the safety and efficacy of its proprietary MicroPulse® technology for treating glaucoma and retinal disease at the upcoming American Society of Cataract and Refractive Surgery Symposium & Congress (ASCRS) and Association for Research in Vision and Ophthalmo... 
Printer Friendly Version
05/03/17IRIDEX Announces First Quarter 2017 Financial Results
Updates Guidance for Full Year 2017 MOUNTAIN VIEW, Calif., May 3, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months ended April 1, 2017. Recent Financial Results and Highlights Total revenue of $10.5 million for the first quarter of 2017, a 12% decrease year over year Cyclo G6™ glaucoma laser platform revenues in the first quarter of 2017 grew in the low double digits year over year ... 
Printer Friendly Version
04/19/17IRIDEX to Report First Quarter 2017 Financial Results on May 3, 2017
MOUNTAIN VIEW, Calif., April 19, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the first quarter 2017 after the close of trading on Wednesday, May 3, 2017.  The Company's management team will host a corresponding conference call beginning at 2:30 p.m. PT / 5:30 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 3... 
Printer Friendly Version
03/15/17IRIDEX To Present At The Sidoti & Co. Spring 2017 Convention
MOUNTAIN VIEW, Calif., March 15, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the Sidoti & Co. Spring 2017 Convention in New York, NY. Iridex's management is scheduled to present on Wednesday, March 29, 2017 at 3:00pm ET. Interested parties can access the live webcast at www.IRIDEX.com. An archived presentation will also be available on the Company's website. About IRIDEX IRIDEX Corporation... 
Printer Friendly Version
03/08/17IRIDEX Announces Fourth Quarter and 2016 Financial Results and Provides Full Year 2017 Financial Outlook
Cyclo G6™ Glaucoma Laser Platform Fourth Quarter Revenue Up 67% Year-over-Year Record Revenue of $12.5 Million in the Fourth Quarter of 2016 MOUNTAIN VIEW, Calif., March 8, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the three months and full year ended December 31, 2016 and provided its full year 2017 financial outlook. Fourth Quarter and 2016 Financial Highlights Total revenue of $12.5 million for the... 
Printer Friendly Version
02/28/17IRIDEX Launches New FDA-Cleared Probe At The Annual American Glaucoma Society Meeting
The award winning CYCLO G6™ Glaucoma Laser System now offers a treatment with built-in transillumination MOUNTAIN VIEW, Calif., Feb. 28, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) is pleased to announce the availability of the G-Probe™ Illuminate, a new, FDA-cleared probe offering combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation (CPC). The G-Probe Illuminate marks the third member of the family of probes powered by the CYCLO G6™ Glaucoma L... 
Printer Friendly Version
02/28/17IRIDEX To Present At 29th Annual Roth Conference
MOUNTAIN VIEW, Calif., Feb. 28, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the 29th Annual Roth Conference in Orange County, CA. Iridex's management is scheduled to present on Tuesday, March 14, 2017 at 9:30am PT. Interested parties can access the live webcast at www.IRIDEX.com. An archived presentation will be also available on the Company's website. About IRIDEX IRIDEX Corporation was founded in 1989 and is a worldw... 
Printer Friendly Version
02/22/17IRIDEX to Report Fourth Quarter and 2016 Financial Results on March 8, 2017
MOUNTAIN VIEW, Calif., Feb. 22, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it will release financial results for the fourth quarter and 2016 after the close of trading on Wednesday, March 8, 2017.  The Company's management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing (844) 707-0665 for domestic callers or (703) 326-3030 for inter... 
Printer Friendly Version
01/31/17BioTuesdays: Iridex MicroPulse Probes Glaucoma Continuum of Care
... 
Printer Friendly Version
01/09/17IRIDEX Announces Preliminary Unaudited Revenues for 2016 Fourth Quarter and Full Year
MOUNTAIN VIEW, Calif., Jan. 9, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported preliminary revenues of approximately $12.4 to $12.5 million and $46.0 to $46.1 million for the fourth quarter and full year 2016, respectively, meeting the previously provided quarterly and full year guidance provided by the Company.  Revenue growth compared to fourth quarter and full year 2015 was driven by the Company's new flagship Cyclo G6™ glaucoma laser platform that is powered b... 
Printer Friendly Version


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina